Biobanking, Sequencing, Mass Spec, Omics, Assay Development
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
4
NCT04749433
Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS
Phase: Phase 1
Role: Collaborator
Start: Sep 1, 2021
Completion: Mar 30, 2023
Loading map...